Bcl-2 Recombinant Rabbit Monoclonal Antibody [PD01-41]
Usd: 385 Special Discount
Specification
Catalog# HA721235
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PD01-41]
-
WB
-
IHC-P
-
IF-Cell
-
FC
-
Human
-
unconjugated
Safety datasheet
Overview
Product Name
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PD01-41]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human Bcl2 alpha aa 50-150 (N terminal).
Species Reactivity
Human
Validated Applications
WB, IHC-P, IF-Cell, FC
Molecular Weight
Predicted band size: 26 kDa
Positive Control
MCF7 cell lysate, Jurkat cell lysate, HL-60 cell lysate, THP-1 cell lysate, human B-cell lymphoma tissue, human tonsil tissue, human lymph nodes tissue, HeLa, THP-1.
Conjugation
unconjugated
Clone Number
PD01-41
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IHC-P
-
1:1,000-1:5,000
-
IF-Cell
-
1:100
-
FC
-
1:1,000
Target
Function
Proteins of the Bcl-2 family are regulators of apoptosis (programmed cell death) localized to membranes of primarily mitochondria, but also to smooth endoplasmic reticulum and nucleolemma. The fine balance between pro- and anti-apoptotic Bcl-2 family members regulates the cell fate in response to many signalling pathways. Altered expression of the proteins may lead to either premature cell death or to inappropriate cell survival promoting neoplastic growth. Bcl-2, Bax and Bcl-X are the most well known proteins in this family. In neoplastic lesions Bcl-2 upregulation may act by suppression of programmed cell death and extension of the tumour cell life span. Bcl-2 overexpression contributes to increased resistance to chemotherapy. However, the prognostic value of Bcl-2 overexpression is dependent on the tumour type, and in some types BCl-2 may even have a tumour suppressor effect. Overexpression of Bcl-2 is common in many types of cancer, including non-Hodgkin's lymphoma and leukaemias, adenocarcinomas (e.g., prostate, colorectum, stomach, and lung), squamous cell carcinoma, small cell carcinoma, neuroblastoma and various sarcomas. Bcl-2 is helpful in distinguishing follicular lymphoma from reactive follicular hyperplasia. Bcl-2 staining can not be used for differential diagnosis between follicular lymphoma and other types of low-grade B-cell lymphomas since most of the latter also express bcl-2. Monocytoid B-cell hyperplasia contrasts with bcl-2 negativity against positive reaction in 80% of the marginal zone lymphomas. Possibly, Bcl-2 may aid in the differential diagnosis of sarcomas. Tonsil is recommendable as positive and negative tissue control for BCL2. A moderate to strong, predominantly cytoplasmic staining reaction should be displayed in virtually all T-cells and B-cells in the mantle zone of the reactive follicles, whereas the majority of the basal squamous epithelial cells, e.g. lining the tonsillar crypts, must show an at least weak staining intensity. Germinal centre T-cells should be distinctively demonstrated, whereas germinal centre B-cells should be negative.
Background References
1. Cao LH et al. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts. Sci Rep 6:18706 (2016).
2. Chen B et al. Inhibition of miR-29c promotes proliferation, and inhibits apoptosis and differentiation in P19 embryonic carcinoma cells. Mol Med Rep 13:2527-35 (2016).
Sequence Similarity
Belongs to the Bcl-2 family.
Tissue Specificity
Expressed in a variety of tissues.
Post-translational Modification
Phosphorylation/dephosphorylation on Ser-70 regulates anti-apoptotic activity. Growth factor-stimulated phosphorylation on Ser-70 by PKC is required for the anti-apoptosis activity and occurs during the G2/M phase of the cell cycle. In the absence of growth factors, BCL2 appears to be phosphorylated by other protein kinases such as ERKs and stress-activated kinases. Phosphorylated by MAPK8/JNK1 at Thr-69, Ser-70 and Ser-87, wich stimulates starvation-induced autophagy. Dephosphorylated by protein phosphatase 2A (PP2A) (By similarity).; Proteolytically cleaved by caspases during apoptosis. The cleaved protein, lacking the BH4 motif, has pro-apoptotic activity, causes the release of cytochrome c into the cytosol promoting further caspase activity.; Monoubiquitinated by PRKN, leading to increase its stability. Ubiquitinated by SCF(FBXO10), leading to its degradation by the proteasome.
Subcellular Location
Mitochondrion outer membrane, Nucleus membrane, Endoplasmic reticulum membrane, Cytoplasm.
UNIPROT
Synonyms
Apoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
ExpandApoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
D630044D05Rik antibody
D830018M01Rik antibody
Leukemia/lymphoma, B-cell, 2 antibody
Oncogene B-cell leukemia 2 antibody
PPP1R50 antibody
Protein phosphatase 1, regulatory subunit 50 antibody
Bcl 2 antibody
CollapseImages
-
Western blot analysis of Bcl-2 on different lysates with Rabbit anti-Bcl-2 antibody (HA721235) at 1/2,000 dilution and competitor's antibody at 1/2,000 dilution.
Lane 1: MCF7 cell lysate (15 µg/Lane)
Lane 2: Jurkat cell lysate (15 µg/Lane)
Lane 3: HL-60 cell lysate (15 µg/Lane)
Lane 4: THP-1 cell lysate (15 µg/Lane)
Predicted band size: 26 kDa
Observed band size: 25 kDa
Exposure time: 1 minute 30 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA721235) at 1/2,000 dilution and competitor's antibody at 1/2,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of Bcl-2 on different lysates with Rabbit anti-Bcl-2 antibody (HA721235) at 1/1,000 dilution.
Lane 1: Hela-si NT cell lysate (10 µg/Lane)
Lane 2: Hela-si Bcl-2 cell lysate (10 µg/Lane)
Predicted band size: 26 kDa
Observed band size: 26 kDa
Exposure time: 31 seconds;
ECL: merk
4-20% SDS-PAGE gel.
HA721235 was shown to specifically react with Bcl-2 in Hela-si NT cells. Weakened band was observed when Hela-si Bcl-2 sample was tested. Hela-si NT and Hela-si Bcl-2 samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (HA721235, 1/1,000) and Loading control antibody (Rabbit anti-GAPDH, ET1601-4, 1/10,000) were used in 5% BSA at room temperature for 2 hours. Goat Anti-rabbit IgG-HRP Secondary Antibody (HA1001) at 1:100,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human B-cell lymphoma tissue with Rabbit anti-Bcl-2 antibody (HA721235) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA721235) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human tonsil tissue with Rabbit anti-Bcl-2 antibody (HA721235) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA721235) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lymph nodes tissue with Rabbit anti-Bcl-2 antibody (HA721235) at 1/5,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA721235) at 1/5,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunocytochemistry analysis of HeLa cells labeling Bcl-2 with Rabbit anti-Bcl-2 antibody (HA721235) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Bcl-2 antibody (HA721235) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of THP-1 cells labeling Bcl-2 with Rabbit anti-Bcl-2 antibody (HA721235) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Bcl-2 antibody (HA721235) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Application: Flow Cytometry (Intra)
Species: Human
Sample: HeLa (Human cervix adenocarcinoma epithelial cell)
Fixation: 4% Paraformaldehyde, 15 minutes at room temperature.
Permeabilization: 1x Permeabilization Buffer (eBioscience), 15 minutes at room temperature.
Blocking: 1% BSA + 10% normal goat serum, 15 minutes at room temperature.
Antibody dilution buffer: 1x PBS.
Primary antibody: HA721235(1 μg/mL) (Red) compared with Rabbit IgG Isotype Control (HA722127, Green), 15 minutes at room temperature.
Secondary antibody: Goat Anti-Rabbit IgG (iFluor™ 488, HA1121), 15 minutes at room temperature. -
Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Tonsil
Sample: Paraffin-embedded section
Primary antibody dilution: 1/1,000
Antigen retrieval: ER2
Platform: Leica Biosystems BOND® RX
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-026-45597-9
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Nuciferine ameliorates steroid-induced osteonecrosis of the femoral head by inhibiting BMSCs ferroptosis via HIF-1α
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.158070
IF: 8.3
Application: WB
Reactivity: Rat
Publish date: 2026 Mar
-
Silencing of small nuclear ribonucleoprotein polypeptide B inhibits the progression of esophageal squamous cell carcinoma
Journal: Oncology Letters
DOI: 10.3892/ol.2026.15561
IF: 2.2
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Liuwei Dihuang Pills Suppress Hepatocellular Carcinoma via PI3K/AKT/TP53 Pathway: Integrating Network Pharmacology, Metabolomics, and Experimental Validation
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157780
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
The Herbal Compound Miltirone from Salvia miltiorrhiza Targets DJ-1 to Induce Mitophagic Dysfunction and ROS-Dependent Hippo Activation in Gastric Cancer
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157821
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Inflammation-responsive DNA hydrogel integrating probiotic outer membrane vesicles for infection monitoring and precision therapy of diabetic wounds
Journal: Journal Of Controlled Release
DOI: 10.1016/j.jconrel.2025.114594
IF: 11.5
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Punicalagin Promotes Peripheral Nerve Repair by Enhancing Mitophagy via the TLR4/MAPK Signaling Pathway and Facilitating Angiogenesis
Journal: Phytotherapy Research
DOI: 10.1002/ptr.70281
IF: 6.3
Application: WB
Reactivity: Rat
Publish date: 2026 Feb
-
Ethanol-induced liver injury is alleviated by chrysin via increasing MRP2 transporter expression and enhancing the Nrf2-mediated adaptive response
Journal: Naunyn-Schmiedebergs Archives Of Pharmacology
DOI: 10.1007/s00210-025-04774-9
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Journal: Bioorganic Chemistry
DOI: 10.1016/j.bioorg.2025.109210
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Integrated multi-omics elucidates PRNP knockdown-mediated chemosensitization to gemcitabine in pancreatic ductal adenocarcinoma
Journal: Frontiers In Immunology
DOI: 10.3389/fimmu.2025.1667835
IF: 5.9
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Silkworm pupae extract attenuates diabetic kidney disease through inhibiting apoptosis
Journal: Journal Of Functional Foods
DOI: 10.1016/j.jff.2025.106881
IF: 3.8
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Therapeutic Potential of Targeting PCLAF in Endometrial Cancer: Insights from Wnt/β-catenin and p53 Regulatory Mechanisms
Journal: Biochemical And Biophysical Research Communications
DOI: 10.1016/j.bbrc.2025.152092
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Downregulation of miR-27a-3p induces endothelial injury and senescence and its significance in the development of coronary heart disease
Journal: Cellular Signalling
DOI: 10.1016/j.cellsig.2025.111759
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Palmatine ameliorates intestinal epithelial barrier injury in ulcerative colitis via targeting enolase 3
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115110
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Ursolic and oleanolic acids suppress MNNG induced malignant transformation of human gastric mucosal epithelium by regulating the PI3 K/AKT pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-025-03606-3
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
The EZH2/MCM Complex/hTERT axis facilitates hepatocellular carcinoma progression by inhibiting cellular senescence
Journal: Mechanisms Of Ageing And Development
DOI: 10.1016/j.mad.2025.112040
IF: 5.3
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming
Journal: Journal of Colloid and Interface Science
DOI: 10.1016/j.jcis.2025.139625
IF: 9.7
Application: WB
Reactivity: Human
Publish date: 2025 Dec
-
Engineered MEVs for photoreceptor-targeted delivery of USP25 to alleviate diabetic retinopathy
Journal: Journal Of Nanobiotechnology
DOI: 10.1186/s12951-025-03671-w
IF: 12.6
Application: WB
Reactivity: Mouse
Publish date: 2025 Aug
-
ENO1 Regulates Apoptosis Induced by Acute Cold Stress in Bovine Mammary Epithelial Cells
Journal: Animals
DOI: 10.3390/ani15172559
IF: 2.7
Application: WB
Reactivity: Bovine
Publish date: 2025 Aug
-
DCI improves diabetic encephalopathy by modulating the BDNF/NF-κB/GSK-3β pathway
Journal: Experimental Neurology
DOI: 10.1016/j.expneurol.2025.115236
IF: 4.6
Application: WB
Reactivity: Bovine
Publish date: 2025 Apr
-
Japanese encephalitis virus infection induces mitochondrial-mediated apoptosis through the proapoptotic protein BAX
Journal: Frontiers In Microbiology
DOI: 10.3389/fmicb.2024.1485667
IF: 4
Application: WB
Reactivity: Pig
Publish date: 2024 Oct
-
Transcriptomics-based identification of TYROBP and TLR8 as novel macrophage-related biomarkers for the diagnosis of acute rejection after kidney transplantation
Journal: Biochemical And Biophysical Research Communications
DOI:
IF: 3.1
Application: WB
Reactivity: Rat
Publish date: 2024 Mar
-
The Link between Osteoporosis and Frozen Shoulder: Exploring the Therapeutic Effect of TAK715 on Reversing Fibrosis and Protecting against Osteoporosis via the p38 MAPK Signaling Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Transcriptome-based exploration of potential molecular targets and mechanisms of selenomethionine in alleviating renal ischemia–reperfusion injury
Journal: Clinical Science
DOI: 10.1042/CS20230818
IF: 6
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2023 Sept
-
N6-(2-hydroxyethyl)-Adenosine Induces Apoptosis via ER Stress and Autophagy of Gastric Carcinoma Cells In Vitro and In Vivo
Journal: International Journal Of Molecular Sciences
DOI:
IF: 2.86
Application: WB
Reactivity: Human
Publish date: 2020 Aug
Products with the same target and pathway
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F1]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02]
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F3]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R] - BSA and Azide free
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49] - BSA and Azide free
Application: WB,IF-Cell,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [F7-1-A1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
FITC Conjugated Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: FC
Reactivity: Human,Mouse
Conjugate: FITC
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49]
Application: WB,IF-Cell,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated